BAFF is involved in macrophage-induced bortezomib resistance in myeloma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BAFF is involved in macrophage-induced bortezomib resistance in myeloma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 11, Pages e3161
Publisher
Springer Nature
Online
2017-11-03
DOI
10.1038/cddis.2017.533
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Forced expression of human macrophage colony-stimulating factor in CD34+ cells promotes monocyte differentiation in vitro and in vivo but blunts osteoclastogenesis in vitro
- (2017) Carmen P. Montano Almendras et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma
- (2017) E Viziteu et al. LEUKEMIA
- Multiple myeloma in the marrow: pathogenesis and treatments
- (2016) Heather Fairfield et al. Annals of the New York Academy of Sciences
- Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma
- (2016) A. Gutierrez-Gonzalez et al. BLOOD
- Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma
- (2016) Noopur S. Raje et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Milestone Review on How Macrophages Affect Tumor Growth
- (2016) Christophe Caux et al. CANCER RESEARCH
- Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma
- (2016) N. S. Raje et al. CLINICAL CANCER RESEARCH
- Progress and Paradigms in Multiple Myeloma
- (2016) Kenneth C. Anderson CLINICAL CANCER RESEARCH
- Study of pathway cross-talk interactions with NF-κB leading to its activation via ubiquitination or phosphorylation: A brief review
- (2016) Sayantan Ghosh et al. GENE
- The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)
- (2016) Sung-Hsin Kuo et al. JOURNAL OF PATHOLOGY
- Bone marrow stromal cells induced activation of nuclear factor κB signaling protects non-Hodgkin’s B lymphoma cells from apoptosis
- (2016) Tuo Su et al. TUMOR BIOLOGY
- Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy
- (2016) Xinqi Wu et al. Cancer Immunology Research
- Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models
- (2015) Fu-Ming Zi et al. CANCER LETTERS
- Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients
- (2015) M A Frassanito et al. LEUKEMIA
- Proteomic Analysis Reveals Distinct Metabolic Differences Between Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Macrophage Colony Stimulating Factor (M-CSF) Grown Macrophages Derived from Murine Bone Marrow Cells
- (2015) Yi Rang Na et al. MOLECULAR & CELLULAR PROTEOMICS
- Monoclonal Antibodies in Multiple Myeloma Come of Age
- (2015) Noopur Raje et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?
- (2015) P J Hengeveld et al. Blood Cancer Journal
- A critical role for the NFkB pathway in multiple myeloma
- (2015) Oncotarget
- Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
- (2015) Jahangir Abdi et al. Oncotarget
- Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB
- (2015) Yulia N. Demchenko et al. Oncotarget
- Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells
- (2014) J. Wang et al. BLOOD
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma
- (2014) Shu Yang et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- M-CSF Inhibits Anti-HIV-1 Activity of IL-32, but They Enhance M2-like Phenotypes of Macrophages
- (2014) A. Osman et al. JOURNAL OF IMMUNOLOGY
- CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile
- (2014) E. Sierra-Filardi et al. JOURNAL OF IMMUNOLOGY
- An optimized Protocol for Human M2 Macrophages using M-CSF and IL-4/IL-10/TGF-βYields a Dominant Immunosuppressive Phenotype
- (2014) S. Mia et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma
- (2013) L. Bolkun et al. ANNALS OF HEMATOLOGY
- Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin
- (2013) Marie Jaguin et al. CELLULAR IMMUNOLOGY
- The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
- (2013) Fabien B. Vincent et al. CYTOKINE & GROWTH FACTOR REVIEWS
- PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma
- (2012) Y Zheng et al. LEUKEMIA
- Novel Proteasome Inhibitors to Overcome Bortezomib Resistance
- (2011) Amy M. Ruschak et al. JNCI-Journal of the National Cancer Institute
- B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor
- (2010) Fabienne Mackay et al. IMMUNOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now